Reminder: Invitation to Roche’s Pharma Day - Monday, 16th September 2019 Mittwoch, 11. September 2019 - 14:04

Reminder: Invitation to Roche's Pharma Day - Monday, 16th September 2019 The Roche Investor Relations team would like to invite you to the Roche Pharma Day that will take place in London on Monday, 16th September 2019, starting at 9:30am local time. Presentations will be held in the morning, followed by lunch and breakout sessions in the afternoon. The event will finish at 2:45pm local time with a buffet reception held afterwards. The Roche Pharma Day will address the following topics: Bill Anderson: Pharma strategy, Portfolio planning, Productivity and new technologies Teresa Graham: Market opportunities; Pricing & Access Sandra Horning: Late stage pipeline Oncology Paulo Fontoura: Late stage pipeline Neuroscience Break Out sessions (afternoon- will not be webcasted) Cristin Hubbard / Zafar Hakim: Late stage pipeline Immunology & Infectious diseases Atul Dandekar / Sascha Fauser: Late stage pipeline Ophthalmology Bryn Roberts: Digitalisation & Personalized healthcare The event will focus on the overall Pharma strategy including digitalisation and PHC and will also update on the most recent pivotal Phase III studies initiated including NMEs just moved to late stage development. You will have the opportunity to meet all senior management during the event. Presentations will also be publicly available via a live video webcast on > http://ir.roche.com Meeting information: Date/Time (BST): Monday, 16th September 2019 09:00am Registration 09:30am Event starts 2:45pm Event ends followed by a buffet reception Venue Hilton London Tower Bridge 5 More London Place Tooley Street, London SE1 2BY map To register for the event please follow this > link Alternatively, you may dial in to the conference. To expedite the registration process on the day of the event, please pre-register for the conference call, click > here, or dial in using the following dial-in numbers (listen-only mode, no live-access to speakers), 10-15 minutes prior to the scheduled start: +41 (0) 58 310 5000 (Europe and ROW) +44 (0) 207 107 0613 (UK) +1 (1) 631 570 5613 (USA Toll Free) A replay of the webcast will be available on demand at > http://ir.roche.com
Best regards, Karl Mahler Head of Investor Relations	Bruno Eschli Investor Relations Officer
Roche Investor Relations
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com	Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com
Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com	Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com	Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com

Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com	Dr. Lisa Tuomi Phone: +1 650 467 8737 e-mail: tuomi.lisa@gene.com